FDA orders vaping products to be removed from U.S market

- Juul devices and four types of pods -- tobacco and menthol-flavored -- cannot be sold or distributed, the FDA said.
- The agency said it reviewed the company's premarket tobacco product applications.
The
US Food and Drug Administration ordered Juul products removed from the US
market as the agency issued marketing denial orders for its vaping devices and
pods.
"As
a result, the company must stop selling and distributing these products. In
addition, those currently on the U.S. market must be removed, or risk
enforcement action," the FDA said on
Thursday.
Juul
devices and four types of pods -- tobacco and menthol-flavored -- cannot be
sold or distributed, the FDA said.
The
agency said it reviewed the company's premarket tobacco product applications
and determined tJuul Labs' study findings had "insufficient and
conflicting data -- including regarding genotoxicity and potentially harmful
chemicals leaching from the company's proprietary e-liquid pods -- that have
not been adequately addressed."
"The FDA is tasked with ensuring that tobacco products sold in this country meet the standard set by the law, but the responsibility to demonstrate that a product meets those standards ultimately falls on the shoulders of the company," said Michele Mital, acting director of the FDA's Center for Tobacco Products, in the news release.
"As with all manufacturers, JUUL had the opportunity
to provide evidence demonstrating that the marketing of their products meets
these standards. However, the company did not provide that evidence and instead
left us with significant questions. Without the data needed to determine
relevant health risks, the FDA is issuing these marketing denial orders."
The
FDA action focuses on importation, distribution and sales, not individual use,
and it "cannot and will not enforce against individual consumer possession
or use of JUUL products or any other tobacco products."
CNN
has contacted Juul for comment but did not immediately hear back.
Comments
No comments yet.
Leave a Comment